News
-
-
-
-
-
-
PRESS RELEASE
Original-Research: MaaT Pharma SACA (von First Berlin Equity Research GmbH): BUY
First Berlin Equity Research updates BUY recommendation for MaaT Pharma SACA, citing successful €9.1m capital raise with strong investor support for lead drug Xervyteg. Company well-positioned for commercialization -
PRESS RELEASE
Rapport Financier Semestriel 2025
-
PRESS RELEASE
Rapport Financier Semestriel 2025
-
PRESS RELEASE
Rapport Semestriel 2025
-